Kyle Garland, Ph.D., is currently the Vice President of Research & Development at Factor Bioscience Inc., where they orchestrate the advancement of novel cell and gene therapies while serving as a liaison to strategic partners. Previously, Kyle held positions at Eterna Therapeutics, directing R&D activities in genetic medicine and cell therapy, and contributed significantly to immunoengineering research at Vanderbilt University. Kyle earned a Ph.D. in Chemical Engineering from Vanderbilt, focusing on immunoengineering applications for cancer therapy, and holds a B.S. in Bioengineering from Lehigh University.
This person is not in the org chart
This person is not in any teams